Jubilant Ingrevia is currently trading at Rs. 478.90, up by 3.05 points or 0.64% from its previous closing of Rs. 475.85 on the BSE.
The scrip opened at Rs. 478.65 and has touched a high and low of Rs. 486.70 and Rs. 476.75 respectively. So far 10315 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.50 on 07-Sep-2023 and a 52 week low of Rs. 350.80 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 492.40 and Rs. 471.90 respectively. The current market cap of the company is Rs. 7631.96 crore.
The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 17.53% and 30.99% respectively.
Jubilant Ingrevia through its wholly-owned subsidiary, Jubilant Agro Sciences has commissioned state-of-the-art, multipurpose, agro active & intermediate plant to produce value-added products at its manufacturing facility at Bharuch, Gujarat.
The plant is geared towards meeting the rising future global demand for agro actives & intermediates. This plant will be utilised for both its CMO customers and own actives. Jubilant Ingrevia has been synthesising several agro intermediates at its manufacturing facility at Bharuch, Gujarat, and this new plant will further expand its presence in agrochemicals. This plant will primarily cater to insecticides intermediates and actives, fungicides actives, based on company’s core pyridine and non-pyridine value chains.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
| Company Name | CMP |
|---|---|
| BASF India | 3415.65 |
| Tata Chemicals | 719.40 |
| SRF | 2704.90 |
| Pidilite Inds. | 1476.50 |
| Deepak Nitrite | 1679.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: